AAOS 2023: 10 Year Outcomes of Cementless Tantalum Tibial Components in TKA .
Randomized Clinical Trial of Cementless Tantalum Tibial Components: Durable and Reliable at 10 Years
389 patients undergoing total knee arthroplasty were randomized to receive a tantalum cementless tibial component (n=135), a traditional modular cemented tibial component (n=135), or a hybrid monoblock component (n=126). The outcomes of interest included survivorship free of revision and survivorship free of reoperation, the risk of aseptic tibial loosening, the rate of non-progressive radiolucent lines, Knee Society Score (KSS) pain and function scores, and range of motion. Outcomes were assessed at 10 years post-operation. The results revealed no differences in survivorship free of revision and reoperation across the three groups. The risk of aseptic tibial loosening was significantly higher in the traditional group, with no cases in the hybrid monoblock and tantalum cementless groups. The rate of non-progressive radiolucent lines was also significantly higher in the traditional group. No differences in KSS pain, KSS function, or range of motion were observed.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics